AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Updates in the treatment of CLL from EHA 2024: BTK and BCL2 inhibitor combinations, BTK degraders, and more
VJHemOnc Podcast
Exploring novel treatments and potential sequencing strategies for CLL
Exploring the effectiveness and advantages of combining BTK and BCL2 inhibitors, BTK degraders, and addressing different BTK mutations in the treatment of chronic lymphocytic leukemia. The chapter also covers the strategic development of these molecules, long-term follow-up needs, and potential sequencing of drug therapies, along with insights on addressing Richter transformation with CD3, CD20 bi-specific EPCRITAMAM in CLL.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode